Horizons: Perspectives on Psychedelics

"The muses love us just as much, and maybe more, when we allow ourselves to unfurl toward wholeness, and that when we become able to listen closely, I think that what we find is that this wholeness is exactly the place that they've been calling us to all along."" - Artist Caledonia Curry, also known as Swoon, a quote from her 2019 Horizons presentation Unearthing the Medea: The Intersection of Art and Psychedelic Assisted Therapy. Image by Swoon Studio You can watch the fu...ll video and more presentations on our YouTube Channel. #Horizons2019 #Swoon #CaledoniaCurry #art #psychedelictherapy #wholeness

From the 2019 Horizons archives, a presentation by Malynn Utzinger, M.D. "Clinical Trials on Psilocybin as a Treatment for Major Depressive Disorder". Malynn Utzinger, M.D. is the Director of Integrative Medicine, Co-Founder, Usona Institute and Director of Integrative Practices, Promega Corporation. https://buff.ly/2Q65kWb... #MalynnUtzinger #psilocybin #psilocybinresearch #psychedelicresearch #Usona #Horizonsconference #Horizonsconf2019

The Journal of American Medical Association (JAMA), is facing an array of criticism and now an internal investigation due to controversial comments on racism in medicine made by a deputy editor. The controversy began when Dr. Ed Livingston, a deputy editor, said on a Feb. 24 podcast that structural racism no longer existed in the United States. Structural racism is an unfortunate term, said Dr. Livingston, who is white. Personally, I think taking racism out of the convers...ation will help. Many people like myself are offended by the implication that we are somehow racist. The podcast was promoted with a tweet from the journal that said, No physician is racist, so how can there be structural racism in health care? As discussed by Monnica Williams, Ph.D., Nicholas Powers, Ph.D, Carl Hart, Ph.D and others on stage at Horizons in recent years, race-based discrimination and structural inequality is absolutely a factor in health and medicine in the United States, and also affects who can study, discuss, enjoy, and access psychedelics.

The Harvard-affiliated Massachusetts General Hospital recently announced that it was opening a new Center for the Neuroscience of Psychedelics, focusing their research on psilocybin-therapy and its effects on the brain's networks. We see our role as doing science and trying to understand how these things work, said Dr. Jerrold F. Rosenbaum, the center’s director and Mass. General’s former psychiatrist-in-chief. We’re just trying to understand what’s happening in the brain.... For more on MGH's Center for the Neuroscience of Psychedelics, check out https://buff.ly/3cPVGjL #MGH #psychedelicresearch #psychedelicsinboston #psilocybintherapy

Did you check out last week's The New York Times Op Ed by Erza Klein? "Oregon is about to become the first state in the country to try to build a support infrastructure through which psychedelic mushrooms can be woven into everyday life. This framework is different from what we’ve seen before: not legalization, not medicalization, but therapeutic use, in licensed facilities, under the guidance of professionals trained to guide psychedelic experiences. Whoa." #Psychedelics #psychedelicresearch #decriminalizeOregon